Pharma IQ Members

Pre-Clinical (Discovery and Development)

Find out how to fill up your pipeline and increase innovation. Pharma IQ is proud to provide an international, non-biased, central resource, for professionals working in early discovery and preclinical research to exchange ideas on best practice and share case studies on innovation within the area.

504 results
of 46
Contributor: Chanice Henry
Posted: 21/11/2017
Chan
The industry has signaled great anticipation around the potential predictive analytics can bring to the creation of new medicines. Full Content »
Contributor: Joyce El Hokayem
Posted: 21/11/2017
default profile icon
Human Genetics Scientist, Joyce El Hokayem examines the benefits phytomedicine could offer to today’s healthcare systems and the challenges researchers in this market face Full Content »
Contributor: Todd Chermak
Posted: 14/11/2017
Todd Chermak
When we think of innovation we generally think of that ‘light bulb’ moment of change. But according to a report by Bain & Company, 70 percent of all innovation is incremental Full Content »
Contributor: Chanice Henry
Posted: 14/11/2017
Chanice Henry
Drug development approaches a fascinating era as the trend of digitalization introduces sophisticated technologies which can neutralize the costly hazards faced in pharma’s R&D pipelines, according to a new deep-dive study by Pharma IQ Full Content »
Contributor: Chanice Henry
Posted: 14/11/2017
Chan
A breakthrough has advanced scientists one step closer to potentially creating the first commercially viable new antibiotic drug in 30 years. Full Content »
Contributor: Pharma IQ News
Posted: 31/10/2017
Pharma IQ News
Pharma IQ looks at the potential of artificial intelligence in drug discovery. Full Content »
Contributor: Michael A. Popov
Posted: 31/10/2017
default profile icon
Michael A. Popov, Director Researcher at Prime States Quantum Lab applies new strategies to one of the most difficult unsolved problems of modern medicine and molecular genetics – cancer Full Content »
Contributor: Michael A. Popov
Posted: 10/10/2017
default profile icon
Michael, A.Popov, of Prime States Quantum Lab, London - Oxford, UK examines how gaps in our understanding of time, could unlock revolutions in cancer studies and epigenetics Full Content »
Contributor: Roger Humphrey
Posted: 03/10/2017
Roger 2
Frustrated by the fight for prime lab space in the US, life sciences companies are exploring the surrounding suburbs of major clusters for more affordable research facilities. Full Content »
Contributor: Joyce El Hokayem
Posted: 03/10/2017
default profile icon
From a better understanding of cancer genomes, clinicians can select the most suitable treatments available for a cancer patient. Full Content »
Contributor: George Clinical Representative
Posted: 25/09/2017
Georger
As new knowledge about Acute kidney injury is uncovered, a global, multicentre clinical trial works to revolutionise the treatment of renal failure. Full Content »
504 results
of 46